pBlueRIP.TfrOVA Citations (2)

Originally described in: Constitutive class I-restricted exogenous presentation of self antigens in vivo.
Kurts C, Heath WR, Carbone FR, Allison J, Miller JF, Kosaka H J Exp Med. 1996 Sep 1;184(3):923-30. PubMed

---

Articles Citing pBlueRIP.TfrOVA

Articles
Phosphorylation and Stabilization of PD-L1 by CK2 Suppresses Dendritic Cell Function. Zhao X, Wei Y, Chu YY, Li Y, Hsu JM, Jiang Z, Liu C, Hsu JL, Chang WC, Yang R, Chan LC, Qu J, Zhang S, Ying H, Yu D, Hung MC. Cancer Res. 2022 Jun 6;82(11):2185-2195. doi: 10.1158/0008-5472.CAN-21-2300. PubMed
High dose Vitamin C inhibits PD-L1 by ROS-pSTAT3 signal pathway and enhances T cell function in TNBC. Zhao X, Liu M, Li C, Liu X, Zhao J, Ma H, Zhang S, Qu J. Int Immunopharmacol. 2024 Jan 5;126:111321. doi: 10.1016/j.intimp.2023.111321. Epub 2023 Dec 4. PubMed

If you have published an article using this material, please email us at to have your article added to this page.